8-70681262-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001011720.2(XKR9):āc.204G>Cā(p.Lys68Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,613,420 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001011720.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XKR9 | NM_001011720.2 | c.204G>C | p.Lys68Asn | missense_variant | 3/5 | ENST00000408926.8 | NP_001011720.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XKR9 | ENST00000408926.8 | c.204G>C | p.Lys68Asn | missense_variant | 3/5 | 1 | NM_001011720.2 | ENSP00000386141.3 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000195 AC: 49AN: 251200Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135768
GnomAD4 exome AF: 0.000126 AC: 184AN: 1461226Hom.: 1 Cov.: 33 AF XY: 0.000135 AC XY: 98AN XY: 726922
GnomAD4 genome AF: 0.000164 AC: 25AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74412
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2024 | The c.204G>C (p.K68N) alteration is located in exon 3 (coding exon 1) of the XKR9 gene. This alteration results from a G to C substitution at nucleotide position 204, causing the lysine (K) at amino acid position 68 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at